• News
  • Momentum against AMR, as metrics for next Ben...
News - published on 17 Jul 2020

Momentum against AMR, as metrics for next Benchmark take shape

A core group of pharmaceutical companies is making progress against antimicrobial resistance (AMR), as reported in the 2020 Antimicrobial Resistance Benchmark. However, change is not yet happening at the scale needed. Since the 2020 Benchmark was published in January, the Foundation has been talking to companies, investors and other stakeholders about how the pharma industry can move ahead on AMR.

Explore further

Get in touch

Back to top |